Press Room

2020 AIChE Annual meeting

Start
Sunday, November 15, 2020 - 00:00
End
Friday, November 20, 2020 - 00:00
Location: online
2020 AIChE Annual meeting | Hovione

Meet Hovione Scientists virtually at 2020 AIChE Annual Meeting and find their exciting presentations on the latest research and innovations:

 

Date: November 16th, 2020

Title: Reaction Kinetic Model Application to Speed up Development
Author: Filipe Ataíde

Session: Predictive Scale-Up/Scale-Down for Production of Pharmaceuticals

Title: Inverse Gas Chromatography (IGC) of Pharmaceutical Powders:
Harnessing the Power of Adhesion-Cohesion Forces to Improve Pharmaceutical Development

Author: Ricardo Gonçalves

Session: Advancements in Particle Engineering and Material Sciences in Pharmaceutical Process Development

Title: Liquid-Liquid Extractions in API Manufacturing Processes: Is Continuous the Way to Go?
Author: Rui Pina Campos

Session: Continuous Processing in Drug Substance Development and Manufacturing

Date: November 17th, 2020

Title: Modelling Amorphous Solid Dispersions: The Role of Supersaturation, Nucleation and Crystal Growth
Author: Patrícia D. Nunes

Session: Integrated Design for Drug Product Processes

Date: November 18th, 2020

Title: Coupling Reaction Kinetics, Calorimetry and Mixing Studies for Successful Scale-up of Exothermic Reactions
Author: Filipe Ataíde

Session: Mixing Scale-Up and Scale-Down Issues in Pharmaceutical Processes

Date: November 19th, 2020

Title: Teaching Computers to Interpret Mdsc Thermograms
Author: Pedro Monteiro & Teresa Marta

Session: Pharma 4.0: Process Analytical Technology and Modeling

Date: November 20th, 2020

Title: Leveraging Hollow Fibre Membranes and High Boiling Point Organic Solvents in the Production of Enteric Amorphous Solid Dispersions
Author: Rui C. Silva

Session: Particle Engineering in Dissolution Enhancement

Title: Insight into Amorphous Solid Dispersion Dissolution Behavior: Laser-Diffraction and Raman Spectroscopy Holding Hands
Author: Maria Paisana

Session: Particle Engineering in Dissolution Enhancement

 

 

Schedule a meeting with our experts

We will work together to ensure successful scale-up even with the tightest development timelines

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025